Integrating Deep Learning CT-scan Model, Biological and Clinical Variables to Predict Severity of Asthma in Children (BREATHE)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT05140889|
Recruitment Status : Recruiting
First Posted : December 2, 2021
Last Update Posted : February 3, 2022
Artificial intelligence (AI) offers substantial opportunities for healthcare, supporting better diagnosis, treatment, prevention and personalized care. Analysis of health images is one of the most promising fields for applying AI in healthcare, contributing to better prediction, diagnosis and treatment of diseases.
Deep learning (DL) is currently one of the most powerful machine learning techniques. DL algorithms are able to learn from raw (or with little pre-processing) input data and build by themselves sophisticated abstract feature representations (useful patterns) that enable very accurate task decision making. Recently, DL has shown promising results in assisting lung disease analysis using computed tomography (CT) images.
Current severe asthma guidelines recommend high-resolution and multidetector CT as a tool for disease evaluation. CT scans contain prognostic information, as the presence of bronchial wall thickening, air trapping, bronchial luminal narrowing, and bronchiectasis are associated with longer disease duration and disease severity in adults. Only a small number of studies have reported chest CT findings in children with severe asthma, and their relationship to clinical and pathobiological parameters yielded inconsistent results. Thus, to which extent CT scans add prognostic information beyond what can be inferred from clinical and biological data is still unresolved in children.
The project is expected to build an DL-severity score to prognoses severe evolution for children with asthma, using a DL model to capture CT scan prognosis information.
|Condition or disease|
|Asthma in Children|
The aims of this project are:
- to build a large database of clinical, biological and radiological data collected from pediatric patients with severe asthma;
- to design and train a forecaster model based on DL techniques to predict asthma severity in children;
- to estimate transition probabilities between asthma severity levels using a multi-state Markov model taking into account qualitative and quantitative information obtained from CT imaging.
Our evaluation of DL-severity and existing clinical scores in childhood asthma is expected to reveal that emerging methodologies assisted by DL techniques can provide accurate severity predictions, when compared with existing clinical scores. Such an accurate prediction model would allow pediatricians to identify features that are the most indicative of severity and progression of asthma and would be employed to formulate intervention strategies and early medical attention for children.
|Study Type :||Observational [Patient Registry]|
|Estimated Enrollment :||25 participants|
|Target Follow-Up Duration:||36 Months|
|Official Title:||Integrating Deep Learning CT-scan Model, Biological and Clinical Variables to Predict Severity of Asthma in Children|
|Actual Study Start Date :||January 20, 2021|
|Estimated Primary Completion Date :||June 30, 2024|
|Estimated Study Completion Date :||June 30, 2024|
Children with severe asthma
Children who undergo chest CT scan for other reasons than asthma
- Prediction of asthma severity in children [ Time Frame: 3 years ]To build a severity score to prognoses evolution for children with asthma, using a deep-learning model to capture CT scan prognosis information and integrate with clinical and laboratory data obtained from medical records.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT05140889
|Contact: Amelia Licari, MD||+39(0)firstname.lastname@example.org|
|IRCCS Policlinico San Matteo||Recruiting|
|Pavia, Italy, 27100|
|Contact: Amelia Licari, MD email@example.com|
|Principal Investigator:||Amelia Licari, MD||IRCCS Policlinico San Matteo|